0000950170-23-064604.txt : 20231116
0000950170-23-064604.hdr.sgml : 20231116
20231116184907
ACCESSION NUMBER: 0000950170-23-064604
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231114
FILED AS OF DATE: 20231116
DATE AS OF CHANGE: 20231116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Link Matthew
CENTRAL INDEX KEY: 0001565950
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40587
FILM NUMBER: 231415962
MAIL ADDRESS:
STREET 1: 7475 LUSK BLVD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sight Sciences, Inc.
CENTRAL INDEX KEY: 0001531177
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 800625749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 SAND HILL ROAD
STREET 2: BUILDING 3, SUITE 105
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (415) 889-0550
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD
STREET 2: BUILDING 3, SUITE 105
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
ownership.xml
4
X0508
4
2023-11-14
0001531177
Sight Sciences, Inc.
SGHT
0001565950
Link Matthew
C/O SIGHT SCIENCES, INC.
4040 CAMPBELL AVE., SUITE 100
MENLO PARK
CA
94025
false
true
false
false
Chief Commercial Officer
false
Common Stock
2023-11-14
4
A
false
747572
0.00
A
747572
D
Stock Option (Right to Buy)
2.06
2023-11-14
4
A
false
526430
0.00
A
2033-11-14
Common Stock
526430
526430
D
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments commencing October 15, 2024 and continuing through October 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The RSUs have no expiration date.
Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable as to 25% of the underlying shares on September 11, 2024, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on September 11, 2027.
/s/ Jeremy Hayden, Attorney-in-Fact for Matthew Link
2023-11-16